EUVIMEDEUVIMED entdecken
Crossref

Construction of 89 Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging

Xiaonan Wei iD, Chaoquan Lai, Xiaoyang Zhu, Aiyan Ji, Yeshan Qin, Shu Gao, Qiuyu Liu, Yonghao Li, Xuanyan Zhao, Hongyue Lou, Chunrong Qu, Zhen Cheng iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Xiaonan Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China. Hauptthemen laut MEDLINE: Zirconium, Radioisotopes, Positron-Emission Tomography, Melanins. Die Arbeit nennt 35 Literaturangaben. Gefördert von: State Key Laboratory of Drug Research, Chinese Academy of Sciences, Science and Technology Program of Gansu Province, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein (FAP) is an important target for the integrated diagnosis and treatment of tumors. However, FAP-targeted small molecule-based radiopharmaceuticals often face challenges such as low tumor uptake and short tumor retention, which hinder their biomedical and clinical applications. In this study, two radiolabeled FAP-targeted nanoprobes based on melanin nanoparticles (MNPs) were designed and developed in order to evaluate their potential for FAP-targeted theranostics. The excellent metal ion complexing property of melanin allowed 89Zr to be efficiently labeled on the MNP platform. After PEGylated MNPs were modified with small molecules FAPI-04 and GPFAPI-04 and radiolabeled with 89Zr to obtain [89Zr]Zr-F-MNPs and [89Zr]Zr-GPF-MNPs, these two nanoprobes achieved active targeting through FAPI ligands. The radiochemical purity of 89Zr-labeled nanoprobes remained above 90% in fetal bovine serum (FBS) solution in 72 h. In vitro experiments showed that both [89Zr]Zr-F-MNPs and [89Zr]Zr-GPF-MNPs were taken up by FAP high-expressing U87MG cells (2.58 ± 0.07% vs 3.00 ± 0.10% for 2 h; 2.93 ± 0.08% vs 3.62 ± 0.04% for 4 h). For the in vivo study, at 48 h postinjection (p.i.) of the nanoprobe, the U87MG tumor uptake of [89Zr]Zr-F-MNPs and [89Zr]Zr-GPF-MNPs reached 4.83 ± 0.50% ID/g and 5.13 ± 0.38% ID/g, respectively. Blocking experiments further confirmed the FAP-dependent targeting ability. Neither of the two nanoprobes elicited observable adverse effects in vivo. In conclusion, the FAPI-MNPs-based nanoprobe platform, which integrates active targeting and passive accumulation, improves tumor uptake and retention time of FAP-targeted radioligands with excellent biosafety. This study offers a new strategy and platform for the development of FAP-targeted diagnostic and therapeutic probes with promising clinical translation potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumRadioisotopesPositron-Emission TomographyMelaninsRadiopharmaceuticalsNanoparticlesMembrane ProteinsSerine EndopeptidasesNeoplasmsGelatinasesAnimalsMiceHumansCell Line, TumorTissue DistributionMice, NudeEndopeptidasesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

FAPIPET imagingfibroblast activation proteinmelanin nanoparticles

Substanzen

ZirconiumRadioisotopesMelaninsRadiopharmaceuticalsMembrane ProteinsSerine EndopeptidasesGelatinasesEndopeptidasesFibroblast Activation Protein AlphaZirconium-89

Autor:innen und Institutionen

  • Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
  • State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
  • Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, 110169 Shenyang, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.

ORCID-Profile: Xiaonan Wei, Zhen Cheng

Förderung

  • State Key Laboratory of Drug Research, Chinese Academy of Sciences
  • Science and Technology Program of Gansu Province
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Wei, X., Lai, C., Zhu, X., Ji, A., Qin, Y., Gao, S., Liu, Q., Li, Y., Zhao, X., Lou, H., Qu, C., & Cheng, Z. (2025). Construction of 89 Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01192

Vancouver

Wei X, Lai C, Zhu X, Ji A, Qin Y, Gao S, et al. Construction of 89 Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01192

BibTeX
@article{Wei2025,
  author = {Wei, Xiaonan and Lai, Chaoquan and Zhu, Xiaoyang and Ji, Aiyan and Qin, Yeshan and Gao, Shu and Liu, Qiuyu and Li, Yonghao and Zhao, Xuanyan and Lou, Hongyue and Qu, Chunrong and Cheng, Zhen},
  title = {Construction of 89 Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01192}
}
Kostenlos starten →